See more : McChip Resources Inc. (MCCHF) Income Statement Analysis – Financial Results
Complete financial analysis of Touchstone International Medical Science Co., Ltd. (688013.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Touchstone International Medical Science Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Super Crop Safe Limited (SUCROSA.BO) Income Statement Analysis – Financial Results
- oOh!media Limited (OML.AX) Income Statement Analysis – Financial Results
- PolyNovo Limited (PNV.AX) Income Statement Analysis – Financial Results
- PowerFleet, Inc. (AIOT) Income Statement Analysis – Financial Results
- LS Berkshire Hathaway (BRK-B) Tracker ETP Securities (BERK.AS) Income Statement Analysis – Financial Results
Touchstone International Medical Science Co., Ltd. (688013.SS)
About Touchstone International Medical Science Co., Ltd.
Touchstone International Medical Science Co., Ltd. researches and develops, manufactures, and sells surgical staplers worldwide. It offers its products for use in laparoscopic and open surgeries. The company was founded in 2003 and is based in Suzhou, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 253.65M | 232.03M | 213.74M | 163.34M | 172.76M | 119.03M | 89.65M |
| Cost of Revenue | 111.80M | 99.11M | 90.89M | 68.08M | 69.03M | 49.23M | 35.12M |
| Gross Profit | 141.85M | 132.92M | 122.84M | 95.27M | 103.73M | 69.80M | 54.53M |
| Gross Profit Ratio | 55.92% | 57.28% | 57.47% | 58.32% | 60.04% | 58.64% | 60.83% |
| Research & Development | 35.32M | 34.75M | 29.28M | 15.37M | 14.10M | 10.63M | 8.23M |
| General & Administrative | 12.71M | 13.08M | 10.60M | 8.70M | 3.68M | 4.14M | 2.50M |
| Selling & Marketing | 41.61M | 32.92M | 36.89M | 28.58M | 30.65M | 23.39M | 24.22M |
| SG&A | 54.32M | 45.99M | 47.49M | 37.28M | 34.33M | 27.53M | 26.72M |
| Other Expenses | -12.11M | 18.00M | 16.97M | 12.71M | 11.35M | 3.36M | 3.22M |
| Operating Expenses | 95.42M | 98.74M | 93.73M | 65.36M | 59.79M | 47.46M | 41.96M |
| Cost & Expenses | 207.21M | 197.86M | 184.62M | 133.44M | 128.81M | 96.69M | 77.07M |
| Interest Income | 2.47M | 282.72K | 674.36K | 198.13K | 59.17K | 185.08K | 168.20K |
| Interest Expense | 194.76K | 159.97K | 72.97K | 98.53K | 396.58K | 430.60K | 87.75K |
| Depreciation & Amortization | 9.83M | 8.44M | 7.24M | 6.58M | 5.56M | 3.86M | 1.29M |
| EBITDA | 57.98M | 54.80M | 35.64M | 46.88M | 54.65M | 31.53M | 18.25M |
| EBITDA Ratio | 22.86% | 22.87% | 16.68% | 28.32% | 31.57% | 26.32% | 15.40% |
| Operating Income | 46.43M | 44.12M | 28.42M | 34.35M | 45.15M | 23.80M | 13.65M |
| Operating Income Ratio | 18.31% | 19.01% | 13.30% | 21.03% | 26.13% | 20.00% | 15.23% |
| Total Other Income/Expenses | 1.51M | 1.97M | 1.21M | 5.85M | 3.45M | 3.36M | 3.22M |
| Income Before Tax | 47.95M | 46.08M | 46.09M | 40.20M | 48.60M | 27.16M | 16.87M |
| Income Before Tax Ratio | 18.90% | 19.86% | 21.57% | 24.61% | 28.13% | 22.82% | 18.82% |
| Income Tax Expense | 636.05K | 2.89M | 4.67M | 5.25M | 6.59M | 4.03M | 2.97M |
| Net Income | 47.31M | 43.20M | 41.42M | 34.95M | 42.01M | 23.13M | 13.91M |
| Net Income Ratio | 18.65% | 18.62% | 19.38% | 21.40% | 24.32% | 19.43% | 15.51% |
| EPS | 0.60 | 0.54 | 0.52 | 0.44 | 0.53 | 0.39 | 0.23 |
| EPS Diluted | 0.58 | 0.53 | 0.51 | 0.44 | 0.53 | 0.39 | 0.23 |
| Weighted Avg Shares Out | 78.85M | 79.99M | 80.00M | 80.00M | 80.00M | 59.31M | 60.46M |
| Weighted Avg Shares Out (Dil) | 81.57M | 81.50M | 81.21M | 80.00M | 80.00M | 59.31M | 60.46M |
Source: https://incomestatements.info
Category: Stock Reports